肿瘤细胞治疗研究
FRONTIER PAPERS
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1
在治疗前表现出 WT1 特异性细胞和体液免疫自发激活的 UR-PDAC 患者中，内源性 WT1 特异性 CD8+Tn 细胞通过 WT1 靶向化学免疫疗法被工程化为 WT1 特异性记忆 CD8+细胞，从而产生了更优的治疗效果。WT1 靶向化学免疫疗法还通过表位扩展诱导了新抗原特异性免疫反应，导致表达新抗原的 PDAC 细胞被消除，并带来了良好的临床结局。
Case Report: Compromised response of memory-formed bystander T cells after CD19 CAR-T cell therapy following CD20 bispecific antibody therapy.
Gene expression profiling of recipient immune cells induced by 7 × 19 CAR-T cell dosing in a syngeneic mouse model.
Emerging treatment strategies for newly diagnosed diffuse large B-cell lymphoma.
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer.
食管胃结合部（EGJ）癌的肠型和胃型表型表现出不同的分子和免疫特征，这些特征影响预后。肠型以 TP53 突变、NOX1 高表达、免疫细胞浸润增加和更好的生存结局为特征，可能影响 EGJ 癌的预后，并可能指导未来的诊断和治疗方法。
Tumor-associated CD163(+) macrophage as a predictor of tumor spread through air spaces and with CD25(+) lymphocyte as a prognostic factor in resected
我们证明，M2 巨噬细胞密度较高是 STAS 发生率较高的独立预测因素。
Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma.
Tumor immune microenvironment dynamics and outcomes of prognosis in non-muscle-invasive bladder cancer.
Guanylate binding protein 5 is an immune-related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analys
间质模式类别可能反映 OSCC 中癌症相关成纤维细胞的侵袭和免疫调节潜能。GBP5 已被建议作为预测免疫检查点抑制剂预后和治疗疗效的潜在生物标志物。
Impacts of tumor microenvironment during neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.
MEMBER ACCOUNT
登录成功会直接打开下一页。
